Borsa Haberleri

Son finansal haberler · Güncellendi May 23, 2026

▬ mixed

Yapay zeka patlaması, Çin'in çip endüstrisi büyümesini hızlandırıyor, talep tedarik zincirini zorluyor

AI boom accelerates China's chip industry growth as demand strains supply chain

The panel discusses China's semiconductor capacity expansion, with a net takeaway that while China aims for 42% global capacity in …

Yahoo Finance · Mar 25, 2026
▬ mixed

CNBC sunucusu, ABD ticaret açığının 136 milyar dolardan 29 milyar dolara düşmesine şok oldu — 2009'dan beri en düşük seviye. Trump'ın tarifeleri doğru muydu?

CNBC anchor shocked by US trade deficit drop from $136B to $29B — the lowest since 2009. Was Trump right about tariffs?

The panel generally agreed that the $29.4B trade deficit was a one-off anomaly, with gold exports and imports accounting for …

Yahoo Finance · Mar 25, 2026
▬ mixed

Bitcoin ETF'leri Bir Ayda 2,5 Milyar Dolar Çekti, Yıl Sonu Kayıplarını Silmeye Yaklaştı

Bitcoin ETFs Draw in $2.5B in a Month, Close to Erasing YTD Losses

The panel's net takeaway is that while the $2.5B inflow into Bitcoin ETFs is notable, its sustainability is questionable due …

Yahoo Finance · Mar 25, 2026
LRCX
▬ mixed

Lam Research Corporation (LRCX) Büyüyen Çip Karmaşıklığından Faydalanmak İçin Konumlanıyor

Lam Research Corporation (LRCX) is Positioned to Benefit from Growing Chip Complexity

The panelists have mixed views on LRCX, with concerns about China export risks and lack of specific financial data, but …

Yahoo Finance · Mar 25, 2026
▬ mixed

65 Yaşında Yapılan Bu Medicare Hatası Hayatınızın Geri Kalanında Sizi İzleyebilir

This Medicare Mistake at Age 65 Could Haunt You for the Rest of Your Life

The panel agrees that missing the 7-month Medicare enrollment window results in a permanent 10% penalty per year, which can …

Nasdaq · Mar 25, 2026
RKLB ROCK TSLA
▬ mixed

Daha İyi Endüstriyel Stok: Tesla vs. Rocket Lab

Better Industrial Stock: Tesla vs. Rocket Lab

The panel discusses Rocket Lab (RKLB) vs Tesla (TSLA), with RKLB's $816M Space Force contract and smaller market cap offering …

Nasdaq · Mar 25, 2026
▬ mixed

Resesyon Korkuları Geri Döndü: Stratejinizi Neden Değiştirmemelisiniz?

Recession Fears Are Back: Here Is Why That Should Not Change Your Strategy

The panel agrees that dollar-cost averaging works historically, but there's no consensus on whether now is a good time to …

Nasdaq · Mar 25, 2026
NFLX
▬ mixed

Netflix Warner Bros.'dan Vazgeçti. Bu Akıllıca Bir Hamle miydi?

Netflix Walked Away From Warner Bros. Was That a Smart Move?

Netflix's decision to walk away from the Warner Bros. Discovery deal at $83 billion was primarily a capital-allocation decision, preserving …

Nasdaq · Mar 25, 2026
AAPL
▼ bear…

Gelecek Vadedişleri, Wall Street'in Orta Derecede Yükselişle Açılacağını Gösteriyor

Futures Suggest Wall Street To Open Moderately Up

Panel consensus suggests a cautious, bearish outlook. Markets show resilience but underlying data points to labor market cooling, geopolitical risks, …

Nasdaq · Mar 25, 2026
▬ mixed

Hugo Barra'nın Meta'ya Dönüşü, 5 Yıl Sonra Ayrılışının Ardından, Zuckerberg'in Yapay Zeka Aciliyetini Vurguluyor

Hugo Barra's return to Meta 5 years after exit underscores Zuckerberg's AI urgency

Meta's pivot to AI agents is a significant shift, but the panel is divided on its potential success. While some …

CNBC · Mar 25, 2026
▬ mixed

Yasal yapay zeka girişimi Harvey, yatırım turunda 11 milyar dolar değerlemeye ulaştı, VC'ler model şirketlerin ötesine bahislerini yayıyor

Legal AI startup Harvey valued at $11 billion in funding round, as VCs spread bets beyond model companies

The panel is divided on Harvey's $11B valuation, with concerns about sustainability, competition, and liability risks, but also acknowledging its …

CNBC · Mar 25, 2026
▬ mixed

Merck, kanser hattını güçlendirmek için Terns Pharmaceuticals'ı 6,7 milyar dolara satın alıyor

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

Merck's $6.7B acquisition of Terns' leukemia drug is a high-stakes gamble to bridge the Keytruda patent cliff in 2028. While …

CNBC · Mar 25, 2026